A Non-interventional Post Authorisation Safety Study (PASS) of Patients with MoCD Type A Treated with NULIBRY (fosdenopterin)

First published 17/05/2024

Last updated 17/05/2024

EU PAS number:

EUPAS1000000093

Study

Planned

Download as PDF

Documents

Study protocol

Initial protocol

ni-pass-protocol v1.3_7MAY2024.pdf

English (851.41 KB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

ENCePP Seal documents